In Q1 2023, EcoR1 Capital held 40 positions worth $2.9B. They initiated 40 new positions. Their largest holding was PRTA ($561.5M).
Frequently asked questions
What stocks did EcoR1 Capital own in Q1 2023?
EcoR1 Capital held 40 biotech stocks in their 13F portfolio in Q1 2023. Their top positions include PRTA, SRPT, APLS, GLPGF, ANAB. The full holdings table is available on BiotechEdge with position sizes, quarter-over-quarter changes, and AI analysis.
How much was EcoR1 Capital's portfolio worth in Q1 2023?
EcoR1 Capital's tracked biotech portfolio was worth $2.9B across 40 positions, with total assets under management of approximately $5B. Portfolio values are based on 13F filings with the SEC.
What did EcoR1 Capital buy in Q1 2023?
EcoR1 Capital initiated 40 new positions in Q1 2023, including PRTA, SRPT, APLS, GLPGF, ANAB and 35 more. They also increased 0 existing positions.
What did EcoR1 Capital sell in Q1 2023?
EcoR1 Capital did not fully exit any positions in Q1 2023.
Is EcoR1 Capital a biotech fund?
Growth-stage crossover fund investing in life sciences companies from late-stage private rounds through public equity. Named after the EcoR1 restriction enzyme, reflecting the firm's scientific roots. Focuses on platform technologies and novel therapeutic modalities.
Want AI analysis, insider signals, and catalyst overlays for EcoR1 Capital?
View latest EcoR1 Capital portfolio →